课题基金 / 基金详情

项目摘要

项目成果

PHILIP E DAWSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION Abstract: Imagine calling T-cells, macrophages, and antibodies into action by taking a simple pill that instantaneously programs both adaptive and innate arms of the immune system to attack a tumor or virus, preventing infection and halting disease. Such an approach could meet major unmet challenges in biomedical research and therapy. My goal is to develop novel approaches that allow innate and acquired immunity to be purposefully targeted to pathogens of interest. These studies build on recently revealed mechanisms of Toll-like receptor signaling, ideas concerning approaches of targeting their sensing abilities to pathogens of defined interest and insights gained from our own invention of chemically programmed antibodies. Ultimately, these studies will allow scientists to program a variety of immune cells and responses to attack pathogens of interest using a variety of mechanisms. We will apply these results to studies in cancer therapy. Furthermore, we will explore novel approaches that should allow for circulating immunoglobulins induced with covalent vaccines to be programmed to inhibit HIV-1 and flu virus entry. The vaccines that result from these studies may be of both prophylactic and therapeutics utility. I will develop novel chemical approaches aimed at learning how to purposefully target innate immunity, T- cells, and macrophages to defined pathogens. I will apply these developments to create new cancer therapies. I will develop a novel approach to orally available chemically programmed immunity. I will apply developments in orally available chemically programmed immunity towards new vaccine strategies for HIV-1 and flu.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
Genome engineering with custom recombinases.
使用定制重组酶进行基因组工程。
DOI: 10.1016/b978-0-12-801185-0.00004-0
发表时间: 2014
期刊: Methods in enzymology
影响因子: --
作者: [Gaj,Thomas, Barbas3rd,CarlosF]
通讯作者: Barbas3rd,CarlosF
N-Sulfonyl-β-lactam hapten as an effective labeling reagent for aldolase mAb.
N-磺酰基-β-内酰胺半抗原作为醛缩酶单克隆抗体的有效标记试剂。
DOI: 10.1016/j.bmcl.2015.03.011
发表时间: 2015
期刊: Bioorganic & medicinal chemistry letters
影响因子: 2.7
作者: [Inokuma,Tsubasa, Fuller,RobertaP, Barbas3rd,CarlosF]
通讯作者: Barbas3rd,CarlosF
DOI: 10.1016/j.bmc.2017.09.010
发表时间: 2017-11
期刊: Bioorganic & medicinal chemistry
影响因子: 3.5
作者: [M. Nagano;Nancy Carrillo;N. Otsubo;W. Hakamata;Hitoshi Ban;Roberta P. Fuller;Nasir K. Bashiruddin;C. Barbas]
通讯作者: M. Nagano;Nancy Carrillo;N. Otsubo;W. Hakamata;Hitoshi Ban;Roberta P. Fuller;Nasir K. Bashiruddin;C. Barbas
DOI: 10.1021/acs.bioconjchem.6b00432
发表时间: 2016-10-19
期刊: Bioconjugate chemistry
影响因子: 4.7
作者: [Patterson JT, Wilson HD, Asano S, Nilchan N, Fuller RP, Roush WR, Rader C, Barbas CF 3rd]
通讯作者: Barbas CF 3rd
14
    Synthetic Protein Chemistry
    • 批准号:
      8286166
    • 项目类别:
    • 资助金额:
      $36.01万
    • 财政年份:
      2011
    • 负责人:
      PHILIP E DAWSON
    • 依托单位:
    Synthetic Protein Chemistry
    • 批准号:
      8442928
    • 项目类别:
    • 资助金额:
      $34.74万
    • 财政年份:
      2011
    • 负责人:
      PHILIP E DAWSON
    • 依托单位:
    Synthetic Protein Chemistry
    • 批准号:
      8163200
    • 项目类别:
    • 资助金额:
      $36.01万
    • 财政年份:
      2011
    • 负责人:
      PHILIP E DAWSON
    • 依托单位:
    Synthetic Protein Chemistry
    • 批准号:
      8636033
    • 项目类别:
    • 资助金额:
      $36.01万
    • 财政年份:
      2011
    • 负责人:
      PHILIP E DAWSON
    • 依托单位:
    海外基金